Medication info

Encover

Prescription medicationOral
Ingredient · strength
Casein›3.4g / 100mLIsolated Soybean Protein›1.666g / 100mLTricaprylin›0.75g / 100mLSoybean Oil›0.699g / 100mLPerillae Japonicae Semen Oil›0.18g / 100mLPalm Oil›0.334g / 100mLMaltodextrin›14.858g / 100mLPurified Sucrose›1.3g / 100mLSodium Citrate Hydrate›207mg / 100mLPotassium Carbonate›197.7mg / 100mLMagnesium Chloride›155.5mg / 100mLCalcium Chloride Hydrate›117.6mg / 100mLPotassium Citrate›51.27mg / 100mLCalcium Citrate›39.53mg / 100mLMonobasic Potassium Phosphate›9.644mg / 100mLPotassium Chloride›6.03mg / 100mLFerrous Gluconate›3.288mg / 100mLZinc Sulfate›1.934mg / 100mLManganese Sulfate›492.1μg / 100mLCupric Sulfate Hydrate›393.1μg / 100mLVitamin A Oil›1.035mg / 100mLCholecalciferol›0.34μg / 100mLTocopherol Acetate›650μg / 100mLPhytonadione›62.5μg / 100mLThiamine Chloride Hydrochloride›483μg / 100mLRiboflavin Sodium Phosphate›311.4μg / 100mLPyridoxine Hydrochloride›455.9μg / 100mLCyanocobalamin›0.32μg / 100mLSodium Ascorbate›31.6mg / 100mLNicotinamide›2.5mg / 100mLCalcium Pantothenate›1.041mg / 100mLFolic Acid›37.5μg / 100mLBiotin›3.86μg / 100mL
Manufacturer / importer
JW Pharmaceutical
Appearance
A light brown liquid with a milk, coffee, banana, or corn flavor, contained in a square aluminum foil pouch.
Packaging
200 mL, 400 mL
Approval status
Active

MFDS item code 200805993 · Notified 2008.05.29 · Insurance code 644912233,644912234,644912235

Summary

Main use
Improvement of nutritional status in postoperative patients and patients unable to take food orally for an extended period
Who takes it
Adults · Children
Adult dose
As the usual standard dose for adults, administer 1200~2000mL (1200~2000kcal) per day through a nasogastric tube, gastrostomy, or enterostomy into the stomach, duodenum, or jejunum over 12~24 hours per day. The administration rate should be 75~125mL/hour. If oral intake is possible, it may be administered orally once or several times per day. At the start of administration, the usual dose is 400mL (400kcal) per day, diluted with water (to approximately 0.5kcal/mL) and administered at a low rate (100mL/hour or less). Increase the dose while monitoring clinical symptoms, aiming to reach the standard dose within 3~7 days. Adjust the dose, concentration, and administration rate as appropriate according to age, body weight, and symptoms.
Child dose
Children aged 1 month to under 10 years: Initiate administration at a concentration of approximately 0.4kcal/mL, and increase the concentration and dose while monitoring clinical symptoms. The standard dose of 70~100kcal/kg/day is administered orally or enterally via a nasal tube, gastrostomy, or enterostomy at a standard concentration of approximately 0.6~0.8 kcal/mL.

Ingredients

Importer
JW Pharmaceutical

Efficacy & effects

Improvement of nutritional status in postoperative patients and patients unable to take food orally for an extended period

View approved original text

This medication is generally used to improve the nutritional status of patients after surgery. It is particularly useful for supplying nutrition via a tube when oral intake is difficult for a prolonged period. Consequently, it helps to effectively supplement the patient's nutritional deficiencies. This drug plays an important role in the rapid recovery and maintenance of the patient's health. It provides stable nutrition even in situations where oral intake is challenging, supporting physical recovery. Ultimately, it is used for nutritional supplementation in patients post-surgery.

How to take

Adult dose

As the usual standard dose for adults, administer 1200~2000mL (1200~2000kcal) per day through a nasogastric tube, gastrostomy, or enterostomy into the stomach, duodenum, or jejunum over 12~24 hours per day. The administration rate should be 75~125mL/hour. If oral intake is possible, it may be administered orally once or several times per day. At the start of administration, the usual dose is 400mL (400kcal) per day, diluted with water (to approximately 0.5kcal/mL) and administered at a low rate (100mL/hour or less). Increase the dose while monitoring clinical symptoms, aiming to reach the standard dose within 3~7 days. Adjust the dose, concentration, and administration rate as appropriate according to age, body weight, and symptoms.

Child dose

Children aged 1 month to under 10 years: Initiate administration at a concentration of approximately 0.4kcal/mL, and increase the concentration and dose while monitoring clinical symptoms. The standard dose of 70~100kcal/kg/day is administered orally or enterally via a nasal tube, gastrostomy, or enterostomy at a standard concentration of approximately 0.6~0.8 kcal/mL.

Precautions

This medication should not be administered to certain patients. Patients who are allergic to this medication or its components, or those with hypersensitivity to milk proteins may experience serious allergic reactions and should not use it. Additionally, this medication should not be administered to patients with bowel obstruction or severe gastrointestinal dysfunction, as it may cause complications due to inability to pass through the digestive tract. Patients with severe liver or kidney dysfunction should also be cautious, as serious side effects like hepatic coma or increased blood nitrogen levels may occur. Patients with severe diabetes with glucose metabolism abnormalities or congenital amino acid metabolism disorders may also experience worsening symptoms, so they should not be administered this medication. Caution should be exercised when using this drug in patients with short bowel syndrome or acute pancreatitis, as there is a risk of aggravated diarrhea or worsening pancreatitis. Special attention is also needed for patients in a comatose state, unconsciousness, exhibiting severe dehydration symptoms, or with poor kidney function regarding maintenance of fluid balance. Women who are pregnant or may become pregnant should also be administered this medication cautiously due to the risk of fetal malformations from the Vitamin A content. Common gastrointestinal side effects from this medication include diarrhea, abdominal bloating, abdominal pain, nausea, and vomiting. Symptoms such as abnormal liver function tests, skin rash, urticaria, fever, and headache have also been reported. Patients should immediately inform healthcare providers of any unusual symptoms. Severe allergic reactions such as shock or anaphylaxis can occur, so if symptoms like hypotension, dyspnea, facial flushing, or pruritus appear, administration should be stopped immediately, and treatment should be sought. After surgery, gastrointestinal motility should recover and when sufficient oral nutritional intake becomes possible, it is advisable to quickly switch to oral administration. Since there may be deficiencies of vitamins, electrolytes, and trace elements, supplementation may be needed if required. Long-term use may potentially lead to selenium deficiency, so caution should be exercised. The long-term effects of this drug have not been confirmed beyond 35 days, so caution is necessary for prolonged administration. This medication may reduce the efficacy of warfarin if used together, so caution is warranted when used concurrently. Older adults may have diminished physiological functions; thus, dosage and rate of administration should be adjusted carefully. In women in the first trimester of pregnancy, there is a risk of fetal malformations due to excessive Vitamin A intake, so the dosage should be limited and administered with caution. It is also advisable not to use this drug for neonates under 1 month of age or low birth weight infants, as its safety has not been established. This drug is not for intravenous use; therefore, the specified route of administration must be followed, and any adverse event should be carefully monitored initially after administration. When administering, residual content in the stomach should be checked, and thorough cleaning of the tubing should be performed; the container should be shaken well before use, and any damaged preparations should not be used. When warming, high temperatures above 70 degrees should be avoided, and heating must be done by double boiling while unopened. During storage, freezing or high temperatures should be avoided, and it should be used as soon as possible after opening. Additionally, since the plasticizer DEHP included in this medication may leach out, it is recommended to use feeding sets or feeding tubes that do not contain DEHP.

Side effects

  • Diarrhea
  • abdominal distension
  • abdominal pain
  • nausea
  • vomiting
  • abnormal liver function tests
  • constipation
  • skin rash
  • urticaria
  • fever
Show 9 more
  • headache
  • hypotension
  • altered consciousness
  • dyspnea
  • cyanosis
  • chest pain
  • facial flushing
  • pruritus
  • sweating

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; therefore, it should be stored in a container that blocks light, and the ideal storage temperature should be at room temperature, avoiding extremes of heat and cold. Thus, it should be stored safely by avoiding direct sunlight and by staying clear of excessively high temperatures or humid locations.

Appearance and packaging

Appearance

A light brown liquid with a milk, coffee, banana, or corn flavor, contained in a square aluminum foil pouch.

Package unit

200 mL, 400 mL

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.